Abstract
Accurate delineation of the gross tumour volume (GTV) in radiation therapy process is mandatory, especially when sophisticated techniques for radiotherapy delivery are used. Functional imaging, particularly PET and its fusion with anatomical modalities, such as PET/CT, promises to improve detection and characterization of disease. Quantitative accuracy in PET imaging is affected by several factors, which influence PET data so as to accurately delineate volume for radiotherapy planning purpose. Several strategies in using PET for target volume definition in radiotherapy treatment planning are being explored in the last years. In the present paper we give an overview of different techniques proposed to generate PET-based tumour volumes and the potential of their use in the radiation oncology process.
Keywords: PET/CT, tumour volume, radiotherapy
Current Radiopharmaceuticals
Title: Use of Positron Emission Tomography for Target Volume Definition
Volume: 2 Issue: 3
Author(s): Federica Fioroni, Elisa Grassi, Roberto Sghedoni, Marco Antonio Sarti, Annibale Versari, Salvo Diana and Gianni Borasi
Affiliation:
Keywords: PET/CT, tumour volume, radiotherapy
Abstract: Accurate delineation of the gross tumour volume (GTV) in radiation therapy process is mandatory, especially when sophisticated techniques for radiotherapy delivery are used. Functional imaging, particularly PET and its fusion with anatomical modalities, such as PET/CT, promises to improve detection and characterization of disease. Quantitative accuracy in PET imaging is affected by several factors, which influence PET data so as to accurately delineate volume for radiotherapy planning purpose. Several strategies in using PET for target volume definition in radiotherapy treatment planning are being explored in the last years. In the present paper we give an overview of different techniques proposed to generate PET-based tumour volumes and the potential of their use in the radiation oncology process.
Export Options
About this article
Cite this article as:
Fioroni Federica, Grassi Elisa, Sghedoni Roberto, Sarti Antonio Marco, Versari Annibale, Diana Salvo and Borasi Gianni, Use of Positron Emission Tomography for Target Volume Definition, Current Radiopharmaceuticals 2009; 2 (3) . https://dx.doi.org/10.2174/1874471010902030144
DOI https://dx.doi.org/10.2174/1874471010902030144 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents
Current Medicinal Chemistry Plasma Proteins Interaction with Curcumin Nanoparticles: Implications in Cancer Therapeutics
Current Drug Metabolism Targeting the Fibroblast Growth Factor Receptors for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Nanotechnology and Animal Health
Pharmaceutical Nanotechnology Emerging Insight into MAPK Inhibitors and Immunotherapy in Colorectal Cancer
Current Medicinal Chemistry Targeting Aurora Kinases in Cancer Treatment
Current Drug Targets Novel Concepts in the Development of Platinum Antitumour Drugs: An Update
Medicinal Chemistry Reviews - Online (Discontinued) The Role of Non-coding Genome in Cancer-associated Fibroblasts; Stateof- the-Art and Perspectives in Cancer Targeted Therapy
Current Drug Targets The Beneficial Effects of Sulfur-containing Amino Acids on Cisplatininduced Cardiotoxicity and Neurotoxicity in Rodents
Current Medicinal Chemistry The Potential of 11C-acetate PET for Monitoring the Fatty Acid Synthesis Pathway in Tumors
Current Pharmaceutical Biotechnology Curcumin Targets in Inflammation and Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of COX-2 in Oral Cancer Development, and Chemoprevention/ Treatment of Oral Cancer by Selective COX-2 Inhibitors
Current Pharmaceutical Design Recent Advances in Diagnostic and Therapeutic Approaches for Breast Cancer: A Comprehensive Review
Current Pharmaceutical Design Stem Cell Differentiation Stage Factors from Zebrafish Embryo: A Novel Strategy to Modulate the Fate of Normal and Pathological Human (Stem) Cells
Current Pharmaceutical Biotechnology Different Aspects of Head and Neck Squamous Cell Carcinoma: Cancer Stem Cells, their Niche and Targeted Therapy
Current Stem Cell Research & Therapy Exploiting HPV-Induced Carcinogenesis for a Rational Drug Development in Cervical Cancer
Current Cancer Drug Targets Targeting Inhibition of COX-2: A Review of Patents, 2002 - 2006
Recent Patents on Inflammation & Allergy Drug Discovery Hedgehog Signaling and Urological Cancers
Current Drug Targets Pentoxifylline and Local Honey for Radiation-Induced Burn Following Breast Conservative Surgery
Current Clinical Pharmacology Emerging Therapies in the Treatment of Locally Advanced Squamous Cell Cancers of Head and Neck
Recent Patents on Anti-Cancer Drug Discovery